We firmly believe that there is an even more seamless, efficient and personalised way to meet customer needs in the Swiss healthcare sector. That's why we have joined forces to form Switzerland’s largest healthcare network.
Annual report 2022: Galenica is still growing strongly.
With an increase in sales of 4.7% to CHF 4,014.3 million and an adjusted EBIT of CHF 200.8 million (-5.8%), Galenica achieved very good results.
Hundreds of new jobs are waiting for you.
The Galenica network is growing.
We offer a wide range of careers for dedicated talented individuals from all disciplines and at all levels of experience.
Find the right job for you now:
|Aktueller Kurs (@TODO: translate)||71.85 CHF|
|absolute change||+0.75 CHF|
02.06.2023 - 17:30:03
Annual General Meeting 2023
The shareholders elect Markus R. Neuhaus as the new Chair of the Board of Directors and approve all proposals.
Galenica and Shop Apotheke Europe enter into a strategic partnership and establish the leading online pharmacy in Switzerland.
Annual results of the Galenica Group 2022
Galenica achieves strong results in 2022 and increases dividend again
The Galenica network.
«Our success depends on how well we can anticipate the major changes in our society and in the healthcare system and offer adequate solutions. For our customers, for our partners, for our employees and thus also for society in our country!»
Marc Werner, CEO